| NephroGenex Announces the Successful Completion of PYR-210 - NEWS.GNOM.ES |
|
|
NEWS.GNOM.ES Diabetic kidney disease afflicts approximately one-third of all diabetics and is the major cause of ESRD, which is a significant component of healthcare expenditures. Mortality rates for ESRD patients can reach 20% annually. Pyridorin™ has been ... NephroGenex Reaches Agreement with the FDA on a Subpart H Phase 3 Program for |